Today’s Research Reports on Cymbria, Pinetree Capital, Gluskin Sheff + Associates and Manulife Financial

In this article:

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Cymbria Corporation
https://rdinvesting.com/news/?ticker=CYB.TO

Pinetree Capital Ltd.
https://rdinvesting.com/news/?ticker=PNP.TO

Gluskin Sheff + Associates Inc.
https://rdinvesting.com/news/?ticker=GS.TO

Manulife Financial Corporation
https://rdinvesting.com/news/?ticker=MFC.TO

Cymbria's stock edged 0.95% higher Friday, to close the day at $54.99. The stock recorded a trading volume of 2,626 shares, which was below its three months average volume of 4,708 shares. In the last year, Cymbria's shares have traded in a range of 42.00 - 56.30. The share price has gained 30.93% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $54.01 is greater than its 200-day moving average of $51.55. Shares of Cymbria have gained approximately 4.74 percent year-to-date.

Access RDI’s Cymbria Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CYB.TO

On Friday, shares of Pinetree Capital recorded a trading volume of 200 shares, which was below the three months average volume of 4,235 shares. The stock ended the day 2.04% lower at 2.40. The share price has gained 41.18% from its 52 week low with a 52 week trading range of 1.70 - 4.02. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.44 is below its 200-day moving average of $2.54. Shares of Pinetree Capital have fallen approximately 7.69 percent year-to-date.

Access RDI’s Pinetree Capital Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=PNP.TO

Gluskin Sheff + Associates' stock edged 0.34% higher Friday, to close the day at $14.69. The stock recorded a trading volume of 89,059 shares, which was below its three months average volume of 121,188 shares. In the last year, Gluskin Sheff + Associates's shares have traded in a range of 14.15 - 19.20. The stock is currently trading 23.49% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $14.64 is below its 200-day moving average of $15.96. Shares of Gluskin Sheff + Associates are trading at a Price to Earnings ratio of 12.52. Shares of Gluskin Sheff + Associates have fallen approximately 11.77 percent year-to-date.

Access RDI’s Gluskin Sheff + Associates Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GS.TO

On Friday, shares of Manulife Financial recorded a trading volume of 2,847,485 shares, which was below the three months average volume of 4,052,311 shares. The stock ended the day 2.11% lower at 23.24. The stock is currently trading 16.31% below its 52 week high with a 52 week trading range of 22.61 - 27.77. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $24.18 is below its 200-day moving average of $25.76. Shares of Manulife Financial are trading at a Price to Earnings ratio of 23.71. Shares of Manulife Financial have fallen approximately 11.37 percent year-to-date.

Access RDI’s Manulife Financial Corporation Research Report at:
https://rdinvesting.com/news/?ticker=MFC.TO

Our Actionable Research on Cymbria Corporation (TSX :CYB.TO), Pinetree Capital Ltd. (TSX :PNP.TO), Gluskin Sheff + Associates Inc. (TSX :GS.TO) and Manulife Financial Corporation (TSX :MFC.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com


Advertisement